Skip to main content
HAE logo

HAE · Haemonetics Corp

Track HAE — free
Market Cap
$4.78B
Shares
45.50M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-09-15 00:00 UTC 2026 Baird Global Healthcare Conference Conference
2026-09-22 00:00 UTC 19th Annual Barrington Research Virtual Fall Investment Conference Conference

Past events

Date Event Type
2026-08-06 Earnings conference call (announced in 8-K) Earnings call
2026-06-03 Reportable Segment Changes Presentation Presentation
2026-05-07 Earnings conference call (announced in 8-K) Earnings call
2026-02-05 Q3 2026 Haemonetics Corporation Earnings Conference Call Earnings call
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Presentation Conference
2026-01-09 Acquisition of Vivasure Medical Limited Event
2025-11-06 Q2 2026 Haemonetics Corporation Earnings Conference Call Earnings call
2025-08-07 Q1 2026 Haemonetics Corporation Earnings Conference Call Earnings call
2025-05-08 Q4 2025 Haemonetics Corporation Earnings Conference Call Earnings call
2025-01-14 JP Morgan 43rd Annual Healthcare Conference Presentation Conference
2024-01-09 JP Morgan 42nd Annual Healthcare Conference Presentation Conference
2023-10-11 Haemonetics Corporation to Acquire OpSens, Inc. Presentation Presentation
2023-01-10 JP Morgan 41st Annual Healthcare Conference Presentation Conference
2022-09-12 Morgan Stanley 20th Annual Global Conference Presentation Conference
2022-06-29 Haemonetics Corporation Investor Day 2022 Presentation Presentation
2022-03-07 Raymond James Institutional Investors Conference Investor Presentation Conference
2021-03-16 Morgan Stanley Corporate Access Day Investor Presentation Presentation
2021-02-02 Haemonetics’ Acquisition of Cardiva Medical Event
2020-11-13 Jefferies Virtual London Healthcare Conference Presentation Conference
2020-06-01 Jefferies Virtual Healthcare Conference Presentation Conference
2020-03-14 Haemonetics statement on business continuity in response to COVID-19 Event
2020-02-27 Raymond James 41st Annual Investor Presentation Presentation

Source: https://haemonetics.gcs-web.com/

Key facts CIK 313143 CUSIP 405024100 13F (30d) 260 filings 252 filers Visit website Investor relations